- Home
- AWH
as 07-26-2024 4:00pm EST
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 20.5M | IPO Year: | N/A |
| Target Price: | $4.45 | AVG Volume (30 days): | 186.2K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.86 - $6.75 | Next Earning Date: | 08-12-2024 |
| Revenue: | $8,991,000 | Revenue Growth: | 4.46% |
| Revenue Growth (this year): | 19.81% | Revenue Growth (next year): | 107.58% |
Stock Insider Trading Activity of Aspira Women's Health Inc. (AWH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sandford Nicole | AWH | Chief Executive Officer | May 31 '24 | Buy | $2.42 | 9,493 | $22,973.06 | 70,596 | SEC Form 4 |
| Merchant Minh Hoang | AWH | Secretary & General Counsel | Dec 6 '23 | Sell | $3.37 | 980 | $3,302.60 | 0 | SEC Form 4 |
| Sandford Nicole | AWH | President & CEO | Dec 6 '23 | Buy | $3.36 | 5,000 | $16,800.00 | 58,703 | SEC Form 4 |
Latest Aspira Women's Health Inc. News
AWH Breaking Stock News: Dive into AWH Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Aspira Women’s Health Announces Preliminary Second Quarter 2024 OvaSuite Product Volume and Highlights
GlobeNewswire
17 days ago
Aspira Women’s Health Announces Closing of $1.9 Million Private Placement Equity Financing
GlobeNewswire
25 days ago
Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing
Simply Wall St.
a month ago
Insider Buyers At Aspira Women's Health Likely Disappointed With 19% Slide
GlobeNewswire
a month ago
Aspira Women’s Health Provides Commercial, Reimbursement and Cash Guidance Updates
GlobeNewswire
2 months ago
Aspira Women’s Health to Present at the A.G.P. Healthcare Showcase on May 21
GlobeNewswire
2 months ago
Aspira Women’s Health Reports First Quarter 2024 Financial Results
GlobeNewswire
3 months ago
UPDATE -- Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
Compare AWH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AWH Aspira Women's Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.